Hongyan Yang

ORCID: 0000-0003-4755-1857 · 1 paper in corpus · active 2025

Study types

  • article 1
article 2025
Efficacy and safety of HYYK formula for residual follicle revival in premature ovarian insufficiency: a multicenter, randomized, double-blind, placebo-controlled trial protocol
·doi:10.1186/s12906-025-04803-3

BACKGROUND: Premature ovarian insufficiency (POI), a condition impacting women under 40, is rising globally, posing significant risks to fertility, bone health, and cardiovascular function. Conventional hormone replacement therapy (HRT) all…